A randomized study to assess the impact of pharmacist counseling of employer-based health plan beneficiaries with diabetes: The EMPOWER study

Journal of Pharmacy Practice

Volumn 25, Issue 2, 2012, Pages 169-179

  Kraemer, Dale F ^a,b   Kradjan, Wayne A ^a   Bianco, Theresa M ^c   Low, Judi A ^d  

^a OREGON STATE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c Providence Health and Services   (United States)

^d Southwest Washington Medical Center   (United States)

Author keywords

adult; community pharmacy services; diabetes mellitus; outcome assessment (health care); patient education; randomized trial

Indexed keywords

HEMOGLOBIN A1C;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; COST; DIABETES MELLITUS; EMPLOYER; FOLLOW UP; HEALTH CARE UTILIZATION; HEALTH PLAN EMPLOYER DATA AND INFORMATION SET; HUMAN; OUTCOME ASSESSMENT; PATIENT COUNSELING; PATIENT EDUCATION; PATIENT MONITORING; PHARMACIST; SELF CARE;

EID: 84860184584     PISSN: 08971900     EISSN: 15311937     Source Type: Journal    
DOI: 10.1177/0897190011418513     Document Type: Article

References (18)

1. Standards of medical care in diabetes-2010. Diabetes Care. 2010 ; 33 (suppl 1). S11 - S61
2. Cheung BM, Ong KL, Cherny SS, et al. Diabetes prevalence and therapeutic target achievement in the United States, 1999 to 2006. Am J Med. 2009 ; 122 (5). 443-453
3. Cranor CW, Bunting BA, Christensen DB.. The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc (Wash). 2003 ; 43 (2). 173-184
4. Cranor CW, Christensen DB.. The Asheville Project: factors associated with outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc (Wash). 2003 ; 43 (2). 160-172
5. Garrett DG, Bluml BM.. Patient self-management program for diabetes: first year clinical, humanistic, and economic outcomes. J Am Pharm Assoc. 2005 ; 45 (2). 130-137 (Pubitemid 46037305)
6. Fera T, Bluml BM, Ellis WM.. Diabetes Ten City Challenge: final economic and clinical results. J Am Pharm Assoc. 2009 ; 49 (3). 383-391
7. Clifford RM, Davis WA, Batty KT, et al. Effect of a pharmaceutical care program on vascular risk factors in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care. 2005 ; 28 (4). 771-776 (Pubitemid 40434471)
8. United States National Institutes of Health. Clinical Trials. Gov. http://www.clinicaltrials.gov/ct2/show/NCT00254501. Accessed2011.
9. Anonymous. National Community Pharmacists Association (NCPA) and the National Institute for Pharmacist Care Outcomes (NIPCO) credentialing program> http://www.ncpanet.org/education/nipco/diabetes.php. Accessed2015.
10. Kessler RC, Barber C, Beck A, et al. The World Health Organization Health and Work Performance Questionnaire (HPQ). J Occup Environ Med. 2003 ; 45 (2). 156-174 (Pubitemid 36228294)
11. Kessler RC, Ormel J, Demler O, et al. Comorbid mental disorders account for the role impairment of commonly occurring chronic physical disorders: results from the National Comorbidity Survey. J Occup Environ Med. 2003 ; 45 (12). 1257-1266 (Pubitemid 37541939)
12. Wang PS, Beck A, Berglund P, et al. Chronic medical conditions and work performance in the health and work performance questionnaire calibration surveys. J Occup Environ Med. 2003 ; 45 (12). 1303-1311 (Pubitemid 37541945)
13. Anderson RM, Funnell MM, Fitzgerald JT, et al. The Diabetes Empowerment Scale: a measure of psychosocial self-efficacy. Diabetes Care. 2000 ; 23 (6). 739-743 (Pubitemid 30414185)
14. University of Michigan Diabetes Research and Training Center. Diabetes Empowerment Scale, Long Form, PDF. http://www.med.umich.edu/mdrtc/profs/ documents/svi/des5.pdf>. Accessed2015.
15. Fitzgerald JT, Funnell MM, Hess GE, et al. The reliability and validity of a brief diabetes knowledge test. Diabetes Care. 1998 ; 21 (5). 706-710 (Pubitemid 28487059)
16. Matza LS, Yu-Isenberg KS, Coyne KS, et al. Further testing of the reliability and validity of the ASK-20 adherence barrier questionnaire in a medical center outpatient population. Curr Med Res Opin. 2008 ; 24 (11). 3197-3206
17. Hahn SR, Park J, Skinner EP, et al. Development of the ASK-20 adherence barrier survey. Curr Med Res Opin. 2008 ; 24 (7). 2127-2138
18. Rosenbaum PR, Rubin DB.. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983 ; 70 (1). 41-55